CAS: 1315330-17-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 3-(6,7-Dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide REF: 3D-QCC33017CAS: 1315330-17-6 | Min. 95% | To inquire | Wed 15 Jan 25 |
 | TL02-59 REF: TM-T13186CAS: 1315330-17-6 | 95.63% | 69.00 €~903.00 € | Wed 05 Feb 25 |
3-(6,7-Dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide
CAS:1315330-17-6
3-(6,7-Dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide is a potent inhibitor of the human TRPV2 ion channel. It has been shown …
Formula:
C32H34F3N5O4
Purity:
Min. 95%
Molecular weight:
609.6 g/mol
Ref: 3D-QCC33017
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
TL02-59
CAS:1315330-17-6
TL02-59: Fgr inhibitor (IC50=0.03nM), also targets Lyn (0.1nM), Hck (160nM), halts acute myelogenous leukemia growth.
Formula:
C32H34F3N5O4
Purity:
95.63%
Color and Shape:
Solid
Molecular weight:
609.64
- Inhibitors
- Apoptosis
- Tyrosine Kinase/Adaptors
- Hck
- See more categories
- Src
Ref: TM-T13186
| 1mg | 69.00 € | ||
| 5mg | 130.00 € | ||
| 10mg | 205.00 € | ||
| 25mg | 346.00 € | ||
| 50mg | 493.00 € | ||
| 100mg | 671.00 € | ||
| 200mg | 903.00 € | ||
| 1mL*10mM (DMSO) | 169.00 € |
Estimated delivery in United States, on Wednesday 5 Feb 2025
